BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8490118)

  • 1. Racial variation in human leukocyte antigen frequency in insulin-dependent diabetic nephropathy. The South-Eastern Organ Procurement Foundation.
    Freedman BI; Espeland MA; Heise ER; Evans J; Canzanello VJ
    J Am Soc Nephrol; 1993 Feb; 3(8):1467-73. PubMed ID: 8490118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in HLA antigen frequency and hypertensive renal failure.
    Freedman BI; Espeland MA; Heise ER; Adams PL; Buckalew VM; Canzanello VJ
    Am J Hypertens; 1991 May; 4(5 Pt 1):393-8. PubMed ID: 2069771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A race-controlled human leukocyte antigen frequency analysis in lupus nephritis. The South-Eastern Organ Procurement Foundation.
    Freedman BI; Spray BJ; Heise ER; Espeland MA; Canzanello VJ
    Am J Kidney Dis; 1993 Apr; 21(4):378-82. PubMed ID: 8465816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis.
    Freedman BI; Spray BJ; Heise ER
    Am J Kidney Dis; 1994 Mar; 23(3):352-7. PubMed ID: 8128935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DQ matching in cadaveric renal transplantation.
    Freedman BI; Thacker LR; Heise ER; Adams PL
    Clin Transplant; 1997 Oct; 11(5 Pt 2):480-4. PubMed ID: 9361945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1996; ():1-14. PubMed ID: 9286555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is diabetic microangiopathy genetically heterogeneous? HLA and diabetic nephropathy.
    Barbosa J
    Horm Metab Res Suppl; 1981; 11():77-80. PubMed ID: 6947952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens in White and Black South African diabetics.
    Shires R; Maier G; Lustig A; Barnett P; Joffe BI; Seftel HC
    S Afr Med J; 1983 Dec; 64(28):1087-9. PubMed ID: 6582605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA associations with insulin-dependent diabetes mellitus in a sample of the American Black population.
    Reitnauer PJ; Roseman JM; Barger BO; Murphy CC; Kirk KA; Acton RT
    Tissue Antigens; 1981 Mar; 17(3):286-93. PubMed ID: 6947506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA associations in end-stage renal disease due to membranous glomerulonephritis: HLA-DR3 associations with progressive renal injury. Southeastern Organ Procurement Foundation.
    Freedman BI; Spray BJ; Dunston GM; Heise ER
    Am J Kidney Dis; 1994 Jun; 23(6):797-802. PubMed ID: 8203361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Leukocyte Antigens (HLA) Genes Association in Type 1 Diabetic Nephropathy.
    Mihoubi E; Amroun H; Raache R; Bouldjennet F; Meçabih F; Azzouz M; Boudiba A; Mahgoun S; Akachouche M; Salhi N; Touil-Boukoffa C; Abbadi MC; Attal N
    Endocr Metab Immune Disord Drug Targets; 2019; 19(8):1157-1164. PubMed ID: 30806329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HLA phenotypes with hypertension in African Americans and Caucasoid Americans with type II diabetes, a population at risk for renal disease.
    Acton RT; Bell DS; Go RC; Roseman J; Tseng ML; Louv W
    Transplant Proc; 1993 Aug; 25(4):2400-3. PubMed ID: 8356614
    [No Abstract]   [Full Text] [Related]  

  • 13. Beneficial effects of HLA-DR3 gene expression on renal allograft survival in black recipients.
    Ross W; Solomon H; Reese J; Fairchild R; Garvin P; Kurtz M
    Transplant Proc; 1993 Aug; 25(4):2408-10. PubMed ID: 8356616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of race on outcome following kidney and kidney-pancreas transplantation in type I diabetics: the South-Eastern Organ Procurement Foundation experience.
    Douzdjian V; Thacker LR; Blanton JW
    Clin Transplant; 1997 Oct; 11(5 Pt 2):470-5. PubMed ID: 9361943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of HLA frequency differences in races on the access to optimally HLA-matched cadaver renal transplants. The Medical Advisory Committee.
    Lazda VA
    Transplantation; 1992 Feb; 53(2):352-7. PubMed ID: 1738929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-antigen distribution in juvenile diabetics with end-stage nephropathy.
    Pitkänen E; Kuhlbäck B; Tiilikainen A; Lokki ML; Kärkkäinen J
    Ann Clin Res; 1981 Apr; 13(2):91-5. PubMed ID: 7235615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leucocyte antigen and insulin gene regions and nephropathy in type I diabetes.
    Chowdhury TA; Dyer PH; Mijovic CH; Dunger DB; Barnett AH; Bain SC
    Diabetologia; 1999 Aug; 42(8):1017-20. PubMed ID: 10491764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease effects and associations.
    Mitsuishi Y; Cecka JM
    Clin Transpl; 1992; ():371-81. PubMed ID: 1306713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.
    Cowie CC; Port FK; Wolfe RA; Savage PJ; Moll PP; Hawthorne VM
    N Engl J Med; 1989 Oct; 321(16):1074-9. PubMed ID: 2797067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.